In the RIP1-Tag2 model of the pancreatic neuroendocrine cancer, cathepsins B, H, and S, derived from the TAMs, had a predominant, if not exclusive, effect on cancer progression through the reduction of tumor burden, increase in apoptosis, and decrease of angiogenesis [48]. This evidence concerns the gene CTSB and neoplasm.